Literature DB >> 19546457

Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer.

Max Dahele1, Anthony Brade, Shannon Pearson, Andrea Bezjak.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19546457      PMCID： PMC2696529          DOI： 10.1503/cmaj.081291

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.

Authors:  Hiroshi Onishi; Hiroki Shirato; Yasushi Nagata; Masahiro Hiraoka; Masaharu Fujino; Kotaro Gomi; Yuzuru Niibe; Katsuyuki Karasawa; Kazushige Hayakawa; Yoshihiro Takai; Tomoki Kimura; Atsuya Takeda; Atsushi Ouchi; Masato Hareyama; Masaki Kokubo; Ryusuke Hara; Jun Itami; Kazunari Yamada; Tsutomu Araki
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

Review 2.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.

Authors:  N P Rowell; C J Williams
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

3.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Authors:  Robert Timmerman; Ronald McGarry; Constantin Yiannoutsos; Lech Papiez; Kathy Tudor; Jill DeLuca; Marvene Ewing; Ramzi Abdulrahman; Colleen DesRosiers; Mark Williams; James Fletcher
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

4.  Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.

Authors:  Amgad El-Sherif; William E Gooding; Ricardo Santos; Brian Pettiford; Peter F Ferson; Hiran C Fernando; Susan J Urda; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

5.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

Review 6.  Stereotactic radiotherapy for nonsmall cell lung cancer.

Authors:  David Ball
Journal:  Curr Opin Pulm Med       Date:  2008-07       Impact factor: 3.155

7.  Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center.

Authors:  Max Dahele; Shannon Pearson; Tom Purdie; Jean-Pierre Bissonnette; Kevin Franks; Anthony Brade; John Cho; Alex Sun; Andrew Hope; Andrea Marshall; Jane Higgins; Andrea Bezjak
Journal:  J Thorac Oncol       Date:  2008-11       Impact factor: 15.609

8.  Natural history of stage I non-small cell lung cancer: implications for early detection.

Authors:  Dan J Raz; Jason A Zell; S-H Ignatius Ou; David R Gandara; Hoda Anton-Culver; David M Jablons
Journal:  Chest       Date:  2007-05-15       Impact factor: 9.410
  8 in total
  5 in total

1.  Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy.

Authors:  M Giuliani; L R Sampson; O Wong; J Gay; L W Le; B C J Cho; A Brade; A Sun; A Bezjak; A J Hope
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

2.  Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity.

Authors:  V Duncker-Rohr; U Nestle; F Momm; V Prokic; F Heinemann; M Mix; J Reusch; M-B Messmer; N Marschner; C F Waller; W A Weber; A-L Grosu
Journal:  Strahlenther Onkol       Date:  2013-01       Impact factor: 3.621

Review 3.  Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?

Authors:  Haris Bilal; Sarah Mahmood; Bala Rajashanker; Rajesh Shah
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-10

4.  Designing Highly Efficient Temperature Controller for Nanoparticles Hyperthermia.

Authors:  Adeel Bashir; Sikandar Khan; Salem Bashmal; Naveed Iqbal; Sami Ullah; Liaqat Ali
Journal:  Nanomaterials (Basel)       Date:  2022-10-10       Impact factor: 5.719

5.  Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.

Authors:  Nathan P Doupnik; Khalid Hirmiz; Abdulkadir A Hussein; John Agapito; Ming Pan
Journal:  Cureus       Date:  2022-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.